Re-evaluation of PD-1 expression by T cells as a marker for immune exhaustion during SIV infection
about
Characterization of CD8+ T cell differentiation following SIVΔnef vaccination by transcription factor expression profilingCharacteristics of splenic CD8+ T cell exhaustion in patients with hepatitis C.Early skewed distribution of total and HIV-specific CD8+ T-cell memory phenotypes during primary HIV infection is related to reduced antiviral activity and faster disease progressionCytokine/Chemokine responses in activated CD4+ and CD8+ T cells isolated from peripheral blood, bone marrow, and axillary lymph nodes during acute simian immunodeficiency virus infection.Animal models for viral infection and cell exhaustion.Levels of CD56+TIM-3- effector CD8 T cells distinguish HIV natural virus suppressors from patients receiving antiretroviral therapy.Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques.Inhibitory Receptors Beyond T Cell Exhaustion.Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression.Characterization of the first-in-class T-cell-engaging bispecific single-chain antibody for targeted immunotherapy of solid tumors expressing the oncofetal protein claudin 6High production rates sustain in vivo levels of PD-1high simian immunodeficiency virus-specific CD8 T cells in the face of rapid clearance.Dynamics of cytokine/chemokine responses in intestinal CD4+ and CD8+ T Cells during Acute Simian Immunodeficiency Virus InfectionIn vivo blockade of the programmed cell death-1 pathway using soluble recombinant PD-1-Fc enhances CD4+ and CD8+ T cell responses but has limited clinical benefit.Inhibitory Receptor Expression Depends More Dominantly on Differentiation and Activation than "Exhaustion" of Human CD8 T Cells.Immune targeting of PD-1(hi) expressing cells during and after antiretroviral therapy in SIV-infected rhesus macaques.Programmed death-1 & its ligands: promising targets for cancer immunotherapy.Differential Expression of Immune Checkpoint Modulators on In Vitro Primed CD4(+) and CD8(+) T Cells.Reducing persistent polyomavirus infection increases functionality of virus-specific memory CD8 T cells.Primary Immunodeficiency Diseases: Current and Emerging Therapeutics.Early initiation of antiretroviral treatment postSIV infection does not resolve lymphoid tissue activation.Programmed death-1+ T cells inhibit effector T cells at the pathological site of miliary tuberculosis.T cell anergy and activation are associated with suboptimal humoral responses to measles revaccination in HIV-infected children on anti-retroviral therapy in Nairobi, Kenya.Design of the exercise MRI evaluation of HIV-pulmonary arterial hypertension longitudinal determinants (EXALTED) trial.T cell exhaustion: a means or an end?ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral Treatment.Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms.Associations of Simian Immunodeficiency Virus (SIV)-Specific Follicular CD8+ T Cells with Other Follicular T Cells Suggest Complex Contributions to SIV Viremia Control.Low Levels of T Cell Exhaustion in Tuberculous Lung Granulomas
P2860
Q27320870-9E557F31-58F8-4ABB-BC12-097598283A24Q33408423-D4498C58-EAF5-4E2E-81F5-07DB7C11BD6CQ34004816-F0130A2D-F4C1-4BAB-983E-B81C875B6BEDQ34059178-BC9AA035-146E-499B-A5AC-B1A4F969871EQ34267776-8ABE848A-C385-42DC-9CF8-98670FCBB4C1Q35092923-693CDF42-1BAD-4745-9406-C6CBA82E06B3Q35586914-A1D5593D-EA10-4661-93D2-579BF5948AE3Q35783318-481975ED-8B60-4FF9-9C48-958C4196AFC8Q35871953-BF75DCF9-CAC2-4901-8C5B-5E3F2255957CQ36821083-CB6D0248-132C-490E-8285-1A18EDA149A8Q37123414-9B374448-5A8D-4A58-9DDE-AB9B30369633Q37252772-EA5DE3A6-F1AA-41B8-99C5-63F274E32798Q37381314-B864AC88-4BF2-4032-9665-F9138A060F17Q37402534-E7E5C07E-35FC-480B-9003-0B259BCA836FQ37406571-0079A835-7991-4049-A444-93C848D6BB7DQ38562062-66868760-F001-4E9F-8DC4-82CC60341A50Q38845203-7C647E49-6053-4016-A6A5-E13AF5EFBC93Q39034482-75A93B79-4B58-4860-952E-7DDC93B89D77Q40076704-716FC7AA-F72C-4120-BDD1-1A15ADA5CFB3Q40129327-780617E6-B489-4860-8FC2-0863CA9E8FDDQ40528343-F169C153-E3C8-45BA-95B9-39EC2E1669E8Q41295794-3C36B7E5-DB16-453F-9722-B42A74E02F10Q41932248-61C69E24-B532-49D8-A46A-5D07B4901C9AQ43874746-55395C36-9DB3-46CC-9B11-82BA47D4DE02Q47585968-3E674EA7-2B36-41EA-B8E9-B209A1F2CEB0Q52597560-D1CDCB05-F822-48BC-A9BC-8D4C60B4EB83Q54261850-5F987528-539F-4E39-9DBE-138E8A682FE4Q56889855-9C66DE01-CAC9-49C4-905C-E236E8CD54F4
P2860
Re-evaluation of PD-1 expression by T cells as a marker for immune exhaustion during SIV infection
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Re-evaluation of PD-1 expressi ...... xhaustion during SIV infection
@ast
Re-evaluation of PD-1 expressi ...... xhaustion during SIV infection
@en
Re-evaluation of PD-1 expressi ...... xhaustion during SIV infection
@nl
type
label
Re-evaluation of PD-1 expressi ...... xhaustion during SIV infection
@ast
Re-evaluation of PD-1 expressi ...... xhaustion during SIV infection
@en
Re-evaluation of PD-1 expressi ...... xhaustion during SIV infection
@nl
prefLabel
Re-evaluation of PD-1 expressi ...... xhaustion during SIV infection
@ast
Re-evaluation of PD-1 expressi ...... xhaustion during SIV infection
@en
Re-evaluation of PD-1 expressi ...... xhaustion during SIV infection
@nl
P2093
P2860
P3181
P1433
P1476
Re-evaluation of PD-1 expressi ...... xhaustion during SIV infection
@en
P2093
Francois Villinger
Jung Joo Hong
Kenneth Rogers
Praveen K Amancha
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0060186
P407
P577
2013-01-01T00:00:00Z